Key result
Oral synthetic Nod1 ligand FK565 induces site-specific vascular inflammation and coronary arteritis in mice.
Why the study?
The role of nucleotide-binding domain, leucine-rich repeat-containing (NLR) protein family stimulants, particularly Nod1 ligands, in inducing site-specific vascular inflammation was unclear.
Answers are grounded in this paper and cite their sources.
This study establishes the first animal model of coronary arteritis induced by oral administration of a pure synthetic Nod1 ligand, revealing a novel role for Nod1 in vascular inflammation.
Objective— The goal of this study was to investigate the effects of stimulants for a nucleotide-binding domain, leucine-rich repeat-containing (NLR) protein family on human artery endothelial cells and murine arteries. Methods and Results— Human coronary artery endothelial cells were challenged in vitro with microbial components that stimulate NLRs or Toll-like receptors. We found stimulatory effects of NLR and Toll-like receptor ligands on the adhesion molecule expression and cytokine secretion by human coronary artery endothelial cells. On the basis of these results, we examined the in vivo effects of these ligands in mice. Among them, FK565, 1 of the nucleotide-binding oligomerization domain (Nod)-1 ligands induced strong site-specific inflammation in the aortic root. Furthermore, coronary arteritis/valvulitis developed after direct oral administration or ad libitum drinking of FK565. The degree of the respective vascular inflammation was associated with persistent high expression of proinflammatory chemokine/cytokine and matrix metallopeptidase ( Mmp ) genes in each tissue in vivo by microarray analysis. Conclusion— This is the first coronary arteritis animal model induced by oral administration of a pure synthetic Nod1 ligand. The present study has demonstrated an unexpected role of Nod1 in the development of site-specific vascular inflammation, especially coronary arteritis. These findings might lead to the clarification of the pathogenesis and pathophysiology of coronary artery disease in humans.
No takes yet. Share an insight, caveat, or question.
Nishio et al. (2011) studied Vascular inflammation and coronary arteritis. FK565 (Nod1 ligand) was evaluated on Site-specific vascular inflammation and coronary arteritis. Oral administration of the synthetic Nod1 ligand FK565 induced strong site-specific vascular inflammation and coronary arteritis in a mouse model.
Synapse has enriched 10 related papers. Consider them for comparative context: